Stoke Therapeutics (STOK) EPS (Weighted Average and Diluted): 2022-2025
Historic EPS (Weighted Average and Diluted) for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to -$0.65.
- Stoke Therapeutics' EPS (Weighted Average and Diluted) fell 38.30% to -$0.65 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.68, marking a year-over-year increase of 132.38%. This contributed to the annual value of -$1.65 for FY2024, which is 30.67% up from last year.
- Stoke Therapeutics' EPS (Weighted Average and Diluted) amounted to -$0.65 in Q3 2025, which was down 62.50% from -$0.40 recorded in Q2 2025.
- In the past 5 years, Stoke Therapeutics' EPS (Weighted Average and Diluted) registered a high of $1.90 during Q1 2025, and its lowest value of -$0.69 during Q2 2023.
- For the 3-year period, Stoke Therapeutics' EPS (Weighted Average and Diluted) averaged around -$0.29, with its median value being -$0.53 (2023).
- Within the past 5 years, the most significant YoY rise in Stoke Therapeutics' EPS (Weighted Average and Diluted) was 433.33% (2025), while the steepest drop was 38.30% (2025).
- Stoke Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.65 in 2022, then rose by 7.69% to -$0.60 in 2023, then surged by 71.67% to -$0.17 in 2024, then crashed by 38.30% to -$0.65 in 2025.
- Its last three reported values are -$0.65 in Q3 2025, -$0.40 for Q2 2025, and $1.90 during Q1 2025.